Cyntellect, Inc. Launches New Application to Address Current Limitations in Stem Cell Research

SAN DIEGO--(BUSINESS WIRE)--Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, announced today the commercial availability of its Stem Cell Colony Purification Application powered by the LEAP™ Cell Processing Workstation. An important addition to Cyntellect’s Stem Cell Manager suite of software already consisting of automated passaging and uniform embryoid body generation tools, this latest application has been developed to address current limitations in stem cell colony purification, and is a major advancement over existing methods.